Stephen B Duffull


Ontology type: schema:Person     


Person Info

NAME

Stephen B

SURNAME

Duffull

Publications in SciGraph latest 50 shown

  • 2019-02 Development of a nonlinear hierarchical model to describe the disposition of deuterium in mother–infant pairs to assess exclusive breastfeeding practice in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2019-02 The intact nephron hypothesis as a model for renal drug handling in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2019-01 Choosing the Allometric Exponent in Covariate Model Building in CLINICAL PHARMACOKINETICS
  • 2018-12 A factor VII-based method for the prediction of anticoagulant response to warfarin in SCIENTIFIC REPORTS
  • 2018-07 A Review of the Methods and Associated Mathematical Models Used in the Measurement of Fat-Free Mass in CLINICAL PHARMACOKINETICS
  • 2018-02 Exploring inductive linearization for pharmacokinetic–pharmacodynamic systems of nonlinear ordinary differential equations in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2018-01 Selection and Qualification of Simplified QSP Models When Using Model Order Reduction Techniques in THE AAPS JOURNAL
  • 2017-12 A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins in CLINICAL PHARMACOKINETICS
  • 2017-12 Assessing robustness of designs for random effects parameters for nonlinear mixed-effects models in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2017-10 Deterministic identifiability of population pharmacokinetic and pharmacokinetic–pharmacodynamic models in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2017-06 A Population Pharmacokinetic Model for 51Cr EDTA to Estimate Renal Function in CLINICAL PHARMACOKINETICS
  • 2016-05 The Population Pharmacokinetics of d-β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate in THE AAPS JOURNAL
  • 2015-12 Simplification of a pharmacokinetic model for red blood cell methotrexate disposition in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2015-12 Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review in BMC GERIATRICS
  • 2015-11 Evaluation of Approaches to Deal with Low-Frequency Nuisance Covariates in Population Pharmacokinetic Analyses in THE AAPS JOURNAL
  • 2015-11 Prediction of Fat-Free Mass in Children in CLINICAL PHARMACOKINETICS
  • 2015-10 Application of Adaptive DP-optimality to Design a Pilot Study for a Clotting Time Test for Enoxaparin in PHARMACEUTICAL RESEARCH
  • 2014-12 Assessment of the Relationship Between Methotrexate Polyglutamates in Red Blood Cells and Clinical Response in Patients Commencing Methotrexate for Rheumatoid Arthritis in CLINICAL PHARMACOKINETICS
  • 2014-11 Between-subject variability: should high be the new normal? in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2014-10 GFR may not accurately predict aspects of proximal tubule drug handling in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2014-06 Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
  • 2014-03 Impact of Anticholinergic Discontinuation on Cognitive Outcomes in Older People: A Systematic Review in DRUGS & AGING
  • 2014-02 Parameterisation affects identifiability of population models in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2013-12 A robust design for identification of the Parasite Clearance Estimator in MALARIA JOURNAL
  • 2013-08 A semi-mechanistic red blood cell survival model provides some insight into red blood cell destruction mechanisms in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2013-07 The population pharmacokinetics of allopurinol and oxypurinol in patients with gout in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2013-06 A Population Pharmacokinetic Model for Low-Dose Methotrexate and its Polyglutamated Metabolites in Red Blood Cells in CLINICAL PHARMACOKINETICS
  • 2013-01 A Bayesian Dose-Individualization Method for Warfarin in CLINICAL PHARMACOKINETICS
  • 2012-12 Reply to the editor of Journal of Pharmacokinetics and Pharmacodynamics in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2012-12 Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria in MALARIA JOURNAL
  • 2012-08 A reduction in between subject variability is not mandatory for selecting a new covariate in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2012-06 A pharmacokinetic model for the glycation of albumin in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2012-06 Adaptive Optimal Design for Bridging Studies with an Application to Population Pharmacokinetic Studies in PHARMACEUTICAL RESEARCH
  • 2012-04 General practitioners’ perceptions of pharmacists’ new services in New Zealand in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
  • 2012-02 Design of pharmacokinetic studies for latent covariates in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2012 Introduction to Pharmacokinetics in Clinical Toxicology in COMPUTATIONAL TOXICOLOGY
  • 2012-01 Development and Evaluation of a Prototype of a Novel Clotting Time Test to Monitor Enoxaparin in PHARMACEUTICAL RESEARCH
  • 2011-12 Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria in MALARIA JOURNAL
  • 2011-12 Modeling red blood cell survival data in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2011-05 Development of a Bayesian Forecasting Method for Warfarin Dose Individualisation in PHARMACEUTICAL RESEARCH
  • 2011-04 The Pharmacokinetics of Methanol in the Presence of Ethanol in CLINICAL PHARMACOKINETICS
  • 2011-04 Evaluation of graphical diagnostics for assessing goodness of fit of logistic regression models in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2011-01-13 Optimal Design of Pharmacokinetic–Pharmacodynamic Studies in PHARMACOKINETICS IN DRUG DEVELOPMENT
  • 2010-09 Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins in CLINICAL PHARMACOKINETICS
  • 2009-12 Towards optimal design of anti-malarial pharmacokinetic studies in MALARIA JOURNAL
  • 2008-12 Methods to Account for Inaccuracies in the Dosing History When Performing Population Pharmacokinetic Analysis in PHARMACEUTICAL RESEARCH
  • 2008-04 Assessing risk of a prolonged QT interval–a survey of emergency physicians in INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE
  • 2007-04 Application of pharmacokinetic-pharmacodynamic modeling in management of QT abnormalities after citalopram overdose. Reply to A. Manini in INTENSIVE CARE MEDICINE
  • 2007-01 Reply to Dr. Mégarbane et al. regarding “Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose” in INTENSIVE CARE MEDICINE
  • 2006-07 Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose in INTENSIVE CARE MEDICINE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.29980.3a", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5379.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413265.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1008.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1003.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414299.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.271089.5", 
            "type": "Organization"
          }
        ], 
        "familyName": "Duffull", 
        "givenName": "Stephen B", 
        "id": "sg:person.01126715720.45", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
            "0000-0002-6545-9408"
          ]
        }, 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126715720.45", 
          "https://orcid.org/0000-0002-6545-9408"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T13:12", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_1031.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01126715720.45'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01126715720.45'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01126715720.45'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01126715720.45'


     

    This table displays all metadata directly associated to this object as RDF triples.

    33 TRIPLES      11 PREDICATES      19 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01126715720.45 schema:affiliation N9413a111b8654d51aa794e4f8dac22f0
    2 https://www.grid.ac/institutes/grid.1003.2
    3 https://www.grid.ac/institutes/grid.1008.9
    4 https://www.grid.ac/institutes/grid.271089.5
    5 https://www.grid.ac/institutes/grid.413265.7
    6 https://www.grid.ac/institutes/grid.414299.3
    7 https://www.grid.ac/institutes/grid.5379.8
    8 schema:familyName Duffull
    9 schema:givenName Stephen B
    10 schema:identifier N85fd464009754f178e554614d476d2ec
    11 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126715720.45
    12 https://orcid.org/0000-0002-6545-9408
    13 schema:sdDatePublished 2019-03-07T13:12
    14 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    15 schema:sdPublisher N33af6a5e2c1d436bbbbcbf2eeb82fd96
    16 sgo:license sg:explorer/license/
    17 sgo:sdDataset persons
    18 rdf:type schema:Person
    19 N33af6a5e2c1d436bbbbcbf2eeb82fd96 schema:name Springer Nature - SN SciGraph project
    20 rdf:type schema:Organization
    21 N85fd464009754f178e554614d476d2ec schema:name orcid_id
    22 schema:value 0000-0002-6545-9408
    23 rdf:type schema:PropertyValue
    24 N9413a111b8654d51aa794e4f8dac22f0 schema:affiliation https://www.grid.ac/institutes/grid.29980.3a
    25 sgo:isCurrent true
    26 rdf:type schema:OrganizationRole
    27 https://www.grid.ac/institutes/grid.1003.2 schema:Organization
    28 https://www.grid.ac/institutes/grid.1008.9 schema:Organization
    29 https://www.grid.ac/institutes/grid.271089.5 schema:Organization
    30 https://www.grid.ac/institutes/grid.29980.3a schema:Organization
    31 https://www.grid.ac/institutes/grid.413265.7 schema:Organization
    32 https://www.grid.ac/institutes/grid.414299.3 schema:Organization
    33 https://www.grid.ac/institutes/grid.5379.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...